Advertisement
Advertisement
Investor Relations /

IPO Quote Profile

METiS TechBio debuts on Hong Kong stock market and raises HK$2.11 billion (US$269.5 million) from the sale of 201.23 million shares at HK$10.50 each. Photo: Jelly Tse
Banking & finance

Hong Kong-listed firm uses AI to make nano-rockets to deliver life-saving drugs

METiS TechBio debuts on Hong Kong stock market as its CEO compares the drug design start-up to SpaceX for the pharmaceutical industry.

videocam
IPO

Chinese industrial robot maker Inovance joins Hong Kong IPO queue

Banking & finance

Biotech-led boom as 8 China firms flock to Hong Kong’s thriving stock market

IPO

Sigenergy jumps 103% in Hong Kong debut on rising energy storage demand

The Shanghai-based firm’s shares closed at HK$659.50, versus its offer price of HK$324.20 after it raised US$560 million from its IPO.

Visitors learn about products at the booth of Sigenergy Technology during the Solar and Storage Live Africa 2026 in Johannesburg, South Africa, on March 25, 2026. Photo: Xinhua
Visitors learn about products at the booth of Sigenergy Technology during the Solar and Storage Live Africa 2026 in Johannesburg, South Africa, on March 25, 2026. Photo: Xinhua
Banking & finance

Global funds fuel Hong Kong IPO rebound as investors rebalance China portfolios

AI, robotics and energy storage firms make up most of the record-high IPO pipeline in Hong Kong, says Chan.

IPO

Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS

The Shanghai-listed firm is selling 58.55 million shares, pricing them at a 31.2 per cent discount to their last-traded mainland stock price.

Advertisement
Advertisement
Advertisement
Banking & finance

Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates

Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.

Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
Banking & finance

Chinese company to use AI-powered testing to boost profits and fast-track IVF

China’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million from Hong Kong listing.

videocam
Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.

videocam
Banking & finance

Hong Kong attracts wave of biotech IPO filings amid AI drug research boom

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest.

The latest applications come as healthcare and biotechnology equity capital market activity in Hong Kong reached US$15.6 billion last year. Illustration: Shutterstock
Banking & finance

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

Overseas capital tends to cherry-pick a few big-cap pharmaceutical companies rather than buy the biotech sector broadly, according to an analyst. Photo: Handout
Overseas capital tends to cherry-pick a few big-cap pharmaceutical companies rather than buy the biotech sector broadly, according to an analyst. Photo: Handout
IPO

Hong Kong’s IPO pace picks up as 2 mainland Chinese firms get listing approval

Everdisplay Optronics and Galaxis Technology publish post-hearing information packs on the Hong Kong stock exchange.

IPO

HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings

Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.

IPO

Shenzhen-listed Unisplendour abandons plan to raise funds in Hong Kong

The Tsinghua Holdings arm, however, will raise US$800 million via a private share placement on Shenzhen exchange.

Unisplendour was expected to raise US$1 billion from its Hong Kong share sale this year. Photo: Reuters
Made in China 2025

Chinese healthcare firms expand overseas to support growing expat community

Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.

Distinct Healthcare raised HK$284.53 million from its initial public offering in Hong Kong last week. Photo: Handout
Distinct Healthcare raised HK$284.53 million from its initial public offering in Hong Kong last week. Photo: Handout
Hong Kong

AI chip supplier Axera trades flat in Hong Kong debut as investor frenzy cools

Axera attracted HK$22.34 billion from retail investors during the bookbuilding period, marking an oversubscription of 74.4 times.

IPO

China’s biggest pork producer Muyuan flat in Hong Kong share debut

Firm’s US$1.4 billion IPO records lower oversubscription rate than other recent listings, reflecting a cooling of the red-hot market.

Advertisement
Advertisement
Advertisement
IPO

3 Chinese firms add to Hong Kong’s IPO boom with US$2 billion in fundraising

Muyuan Foods, Shenzhen Han’s and Distinct Healthcare started taking orders for their Hong Kong listings on Thursday.

Muyuan Foods, the world’s largest hog firm, plans to sell about 274 million new shares at up to HK$39 each. Photo: Shutterstock
Muyuan Foods, the world’s largest hog firm, plans to sell about 274 million new shares at up to HK$39 each. Photo: Shutterstock
IPO

Chinese drinks maker Eastroc’s US$1.3 billion Hong Kong IPO gives it wings

Shanghai-listed firm is selling 40.9 million shares for HK$248 each, which would give it a market cap of about US$21 billion.

Mainland China

China’s rocket start-ups push the envelope as IPOs gather pace

A policy-backed push to build commercial space champions is reshaping China’s IPO pipeline, with regulators signalling faster pathways.

IPO

China’s Busy Ming to test investor appetite with Hong Kong IPO

Snack and drink retailer aims to raise up to US$428 million, but listing plan comes amid weak mainland domestic demand.

Hong Kong’s IPO market has had a record January with 11 new listings raising more than US$4.3 billion. Photo: Nora Tam
IPO

Chinese AI start-up MiniMax shines on Hong Kong IPO debut

The shares jump as much as 113.2 per cent to HK$351.80 before ending the day 109.1 per cent higher at HK$345.

Executives of MiniMax Group, Suzhou Ribo Life Science, Yunnan Jinxun Resources and HKEX at the IPO listing ceremony on Friday. Photo: Jonathan Wong
Executives of MiniMax Group, Suzhou Ribo Life Science, Yunnan Jinxun Resources and HKEX at the IPO listing ceremony on Friday. Photo: Jonathan Wong
Banking & finance

TCM firms eye Hong Kong IPOs to fuel global expansion

Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.

IPO

3 Chinese AI, robotics stocks gain in Hong Kong debuts

Zhipu AI, Iluvatar CoreX and Edge Medical raised US$1.2 billion in their share offerings.

IPO

MiniMax’s Hong Kong IPO set to hit US$538 million amid Chinese AI sector frenzy

The Alibaba-backed firm is set to price its 25.4 million shares at HK$165 each, the top end of its marketed range, sources say.

MiniMax, founded in early 2022 by former SenseTime veteran Yan Junjie, develops multimodal AI models. Photo: Shutterstock
Help preserve 120 years of quality journalism.
SUPPORT NOW